David Hogarty
Goldsboro, NCNPI 1760447528
Payments from drug & device makers
$2,897in general payments, 2019–2025
Across 172 payments — averaging $16.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$954
- Johnson & Johnson$382
- AbbVie$323
- UCB, Inc.$282
- Actelion Pharmaceuticals US, Inc.$164
- Lilly USA, LLC$163
- plus $629 from 14 others
What the payments were for
- Food & beverage$2,897100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
19
20
21
23
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 55 | $954 |
| Johnson & Johnson(2 entities) | 24 | $382 |
| AbbVie | 19 | $323 |
| UCB, Inc. | 20 | $282 |
| Actelion Pharmaceuticals US, Inc. | 8 | $164 |
| Lilly USA, LLC | 9 | $163 |
| Regeneron Healthcare Solutions, Inc. | 7 | $103 |
| Pfizer | 7 | $90 |
| Akcea Therapeutics, Inc. | 1 | $88 |
| Fidia Pharma USA Inc. | 4 | $79 |
| Boehringer Ingelheim | 4 | $52 |
| Hikma Pharmaceuticals USA | 3 | $45 |
| AstraZeneca(2 entities) | 2 | $33 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| Sanofi | 2 | $24 |
| Mallinckrodt Enterprises LLC | 1 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $18 |
| Radius Health, Inc. | 1 | $16 |
| Medexus Pharma, Inc. | 1 | $15 |
| Aurinia Pharma U.S., Inc. | 1 | $15 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.